ERNA Ernexa Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 11, 2026
$2.96
· of 52w range
· above low
· to high
$0.1852w low
$15.8852w high
Market Cap (MRQ)
$3M
your badges
52W Range
$0–$16
Analyst Rating
BUY
Price Target
$30
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ERNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.96
Market Cap (MRQ)
$3M
52W Range
$0–$16
ERNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 4, 2026 | 1-for-25 | Reverse |
| June 12, 2025 | 1-for-15 | Reverse |
| Oct. 17, 2022 | 1-for-20 | Reverse |
| March 26, 2021 | 1-for-2 | Reverse |
| June 17, 2016 | 1-for-50 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ERNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.5 | · | 0.3 | Undervalued |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ERNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.9 | · | 4.3 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
5.9%
Next Report
Nov 05, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $-3.40 | $-3.37 | -1.0% |
| Sept. 30, 2023 | $-1.03 | — | — | |
| Sept. 30, 2022 | $-933.75 | $-841.50 | -11.0% | |
| June 30, 2022 | $-450.00 | $-994.50 | 54.8% | |
| March 31, 2022 | $-1275.00 | $-1071.00 | -19.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
No annual filings for ERNA
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q1 2026 |
|---|---|---|
| SG&A Expense | $2M | |
| Operating Expenses | $6M | |
| Operating Income | $-6M | |
| Pretax Income | $-6M | |
| Income Tax | $-40.0K | |
| Net Income | $-6M | |
| EPS (Basic) | $-6.95 | |
| EPS (Diluted) | $-6.95 | |
| Shares (Basic) | 792,000 | |
| Shares (Diluted) | 792,000 | |
| EBITDA | $-6M |
Balance Sheet
| Metric | Trend | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $9M | |
| Prepaid Expense | $724.0K | |
| Current Assets | $10M | |
| PP&E (Net) | $88.0K | |
| Other Non-current Assets | $110.0K | |
| Total Assets | $11M | |
| Accounts Payable | $1M | |
| Accrued Liabilities | $1M | |
| Current Liabilities | $3M | |
| Capital Leases | $226.0K | |
| Other Non-current Liabilities | $1.0K | |
| Total Liabilities | $4M | |
| Common Stock | $6.0K | |
| Paid-in Capital | $258M | |
| Retained Earnings | $-251M | |
| Stockholders' Equity | $7M | |
| Liabilities + Equity | $11M | |
| Shares Outstanding | 1,166,000 |
Cash Flow
| Metric | Trend | Q1 2026 |
|---|---|---|
| D&A | $8.0K | |
| Stock-based Comp | $309.0K | |
| Other Non-cash | $3M | |
| Operating Cash Flow | $-2M | |
| CapEx | $2.0K | |
| Investing Cash Flow | $-2.0K | |
| Stock Issued | $10M | |
| Net Stock Activity | $10M | |
| Financing Cash Flow | $10M | |
| Free Cash Flow | $-2M |
Profitability
| Metric | Trend | Q1 2026 |
|---|---|---|
| ROA | -70.6% | |
| ROE | -1211.4% | |
| ROIC | -80.9% |
Liquidity & Solvency
| Metric | Trend | Q1 2026 |
|---|---|---|
| Current Ratio | 2.9 | |
| Quick Ratio | 2.7 |
Per Share
| Metric | Trend | Q1 2026 |
|---|---|---|
| Book Value / Share | $5.88 | |
| Cash Flow / Share | $-2.86 | |
| Cash / Share | $7.87 | |
| EPS (TTM) | $-23.62 |
Valuation (TTM)
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue TTM | $582.0K | |
| Net Income TTM | $-11M | |
| Market Cap | $233.2K | |
| P/E | -0.0 | |
| P/S | 0.4 | |
| P/B | 0.0 | |
| P / Tangible Book | 0.0 | |
| P / Cash Flow | -0.1 | |
| Earnings Yield | -11810.0% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 1 filer · $43K total · As of Dec. 31, 2025
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
1
Value held
$43K
New positions
11
Exited positions
4
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (+8 vs prior Q) | 4 (+1 vs prior Q) | 3 (0 vs prior Q) | 0 (-1 vs prior Q) | +3.1M |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43,106 | 35,922 | 100.00% | Shares |
Activists & 5%+ owners 17 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Charles Cherington ×8 filings | Feb. 17, 2026 | 34.70% | Amendment | · | SEC |
| Nicholas Jason Singer ×2 filings | July 26, 2023 | · | Initial filing | · | SEC |
| Ault Global Holdings, Inc. ×2 filings | March 17, 2021 | · | Initial filing | · | SEC |
| Robert S. Ellin, Trinad Capital Master Fund, Ltd., Trinad Capital Management, LLC, JJAT Corp. ×3 filings | Aug. 18, 2020 | · | Initial filing | · | SEC |
| Sean Gordon ×3 filings | July 8, 2019 | · | Initial filing | Passive investment | SEC |
| Ram Krishnan | March 21, 2019 | · | Initial filing | · | SEC |
| North Star Investment Management Corporation | Nov. 21, 2018 | · | Initial filing | Board campaign | SEC |
| Matador Capital Partners, L.P., BFK Investments LLC, Jeffrey A. Berg ×6 filings | July 2, 2018 | · | Initial filing | · | SEC |
| Trinad Capital Master Fund, Ltd., Trinad Management, LLC, Robert S. Ellin ×21 filings | Feb. 6, 2013 | · | Initial filing | · | SEC |
| JABAM, Inc., BFK Investments LLC, Jeffrey A. Berg, Matador Capital Partners, L.P. ×3 filings | Jan. 14, 2011 | · | Initial filing | Passive investment | SEC |
| Fidelity National Financial, Inc., Security Union Title Insurance Company, Alamo Title Insurance, Ticor Title Insurance Company, Chicago Title Insurance Company, Fidelity National Title Insurance Company ×2 filings | Aug. 20, 2009 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | Sept. 23, 2008 | · | Initial filing | · | SEC |
| May 23, 2008 | · | Initial filing | · | SEC | |
| Sept. 18, 2007 | · | Initial filing | · | SEC | |
| July 27, 2005 | · | Initial filing | · | SEC | |
| Feb. 3, 2004 | · | Initial filing | · | SEC | |
| May 20, 2003 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 76 insiders · 38 officers · 38 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Sanjeev Luther | President & CEO | Feb. 7, 2025 A | · | 0 | 0 | $0 |
| Matthew Angel | President and CEO | Jan. 12, 2023 A | · | 0 | 0 | $0 |
| Howard J. Federoff | CEO & President | March 11, 2022 A | · | 0 | 0 | $0 |
| Allen Wolff | Former Director and CEO | March 24, 2021 F | 128,520 | 0 | 0 | $0 |
| Ram Krishnan | CEO | Aug. 27, 2019 F | 102,375 | 0 | 0 | $0 |
| Michael J Bush | CEO | Feb. 24, 2012 M | 420,385 | 0 | 0 | $0 |
| Michael K Fleming | Interim CEO | June 9, 2008 A | · | 0 | 0 | $0 |
| Dario Loreto Santana | President and CEO | Aug. 20, 2007 P | 75,000 | 0 | 0 | $0 |
| Stanley B Kinsey | Chief Executive Officer | June 28, 2005 A | · | 0 | 0 | $0 |
| Andrew C. Jackson | Chief Financial Officer | June 3, 2022 A | · | 0 | 0 | $0 |
| Kendra Berger | Chief Financial Officer | Aug. 6, 2012 A | 188,750 | 0 | 0 | $0 |
| James B Frakes | Chief Financial Officer | Sept. 30, 2004 A | · | 0 | 0 | $0 |
| Mark De Gorter | President & COO, NTN Hosp Tech | June 27, 2005 A | · | 0 | 0 | $0 |
| Victor Tyrone Lam | President | March 22, 2004 A | · | 0 | 0 | $0 |
| Robert J Cooney | Chief Operating Officer | Jan. 23, 2014 A | · | 0 | 0 | $0 |
| Sandra M Gurrola | Sr. VP of Finance | June 21, 2025 M | 110 | 0 | 0 | $0 |
| Dorothy J Clarke | General Counsel | Jan. 1, 2024 A | · | 0 | 0 | $0 |
| Roger Sidhu | Chief Medical Officer | Sept. 20, 2022 M | 20,163 | 0 | 0 | $0 |
| Kevin Damour | Chief Scientific Officer | June 28, 2022 M | 11,496 | 0 | 0 | $0 |
| Jay Sial | Chief Administration Officer | March 11, 2022 A | · | 0 | 0 | $0 |
| Dave Brian Miller | SVP Marketing | Nov. 4, 2016 A | 13,131 | 0 | 0 | $0 |
| William Thomas | SVP Marketing | May 12, 2014 A | · | 0 | 0 | $0 |
| Vladimir Khuchua | CHIEF DEVELOPMENT OFFICER | May 5, 2014 A | 272,700 | 0 | 0 | $0 |
| Kirk Nagamine | Chief Revenue Officer | April 15, 2013 A | · | 0 | 0 | $0 |
| Barry Chandler | Chief Marketing Officer | Jan. 31, 2013 A | 250,000 | 0 | 0 | $0 |
| Christopher Allen George | Chief Information Officer | Aug. 6, 2012 A | 60,600 | 0 | 0 | $0 |
| Peter A. Duckett | SVP of Sales | March 26, 2012 A | · | 0 | 0 | $0 |
| Nicholas A Glassman | EVP OF PROGRAMMING/TECHNOLOGY | May 10, 2010 A | 10,000 | 0 | 0 | $0 |
| Kenneth L Keymer | Chief Operations Officer | July 27, 2009 A | 49,900 | 0 | 0 | $0 |
| Kartik V. Ramachandran | Chief Strat Off, EVP Bus Dev | April 24, 2009 A | · | 0 | 0 | $0 |
| Michael A Arzt | Executive VP of Marketing | Jan. 30, 2009 A | · | 0 | 0 | $0 |
| Jake Tauber | EVP Content & Marketing | Aug. 12, 2008 A | 18,750 | 0 | 0 | $0 |
| Peter James Boylan III | Executive Vice President Sales | July 15, 2008 A | 18,750 | 0 | 0 | $0 |
| John Gaffney | Sr. V.P. Product Management | Feb. 4, 2008 A | · | 0 | 0 | $0 |
| Jennifer Bourbiel | Vice President, Marketing | Sept. 4, 2007 A | 15,000 | 0 | 0 | $0 |
| John Boozer | SR. VP, Global Sales | Aug. 17, 2007 M | 3,000 | 0 | 0 | $0 |
| Mariana Danilovic | Ex. VP, Business Development | Aug. 14, 2007 A | · | 0 | 0 | $0 |
| Michele Richards | CTO & Sr. VP, Operations | April 23, 2007 A | · | 0 | 0 | $0 |
| Peter Cicala | Director | Feb. 7, 2025 A | · | 0 | 0 | $0 |
| William A. Wexler | Director | Feb. 7, 2025 A | · | 0 | 0 | $0 |
| James Arthur Bristol | Director | Feb. 7, 2025 A | · | 0 | 0 | $0 |
| Elena Ratner | Director | Jan. 13, 2025 A | · | 0 | 0 | $0 |
| Richard W Wagner | Director | July 13, 2023 P | · | 0 | 0 | $0 |
| BINDER BRANT | Director | July 13, 2023 P | · | 0 | 0 | $0 |
| Nicholas Jason Singer | Director | Dec. 2, 2022 P | 266,214 | 0 | 0 | $0 |
| Gregory Fiore | Director | Aug. 1, 2022 A | · | 0 | 0 | $0 |
| Heather B Redman | Director | Jan. 14, 2022 A | · | 0 | 0 | $0 |
| Erin S. Enright | Director | Jan. 14, 2022 A | · | 0 | 0 | $0 |
| Luba Greenwood | Director | Dec. 8, 2021 A | · | 0 | 0 | $0 |
| Erich Mohr | Director | Dec. 8, 2021 A | · | 0 | 0 | $0 |
| Dennis Langer | Director | Dec. 8, 2021 A | · | 0 | 0 | $0 |
| Richard Isaac Simtob | Director | Dec. 31, 2019 A | 55,939 | 0 | 0 | $0 |
| Michael Gottlieb | Director | Nov. 26, 2019 A | · | 0 | 0 | $0 |
| Susan Elaine Miller | Director | Aug. 30, 2019 A | · | 0 | 0 | $0 |
| Gregory Matthew Thomas | Director | June 7, 2019 A | 2,337 | 0 | 0 | $0 |
| Paul Yanover | Director | June 7, 2019 A | 1,163 | 0 | 0 | $0 |
| Steve Mitgang | Director | June 7, 2019 A | 1,813 | 0 | 0 | $0 |
| Tony Uphoff | Director | June 8, 2017 A | 9,600 | 0 | 0 | $0 |
| Mary Beth Lewis | Director | June 8, 2017 A | 30,000 | 0 | 0 | $0 |
| Terry Allan Bateman | Director | June 8, 2012 A | 503,958 | 0 | 0 | $0 |
| Joseph J. Farricielli Jr. | Director | June 15, 2009 P | 110,000 | 0 | 0 | $0 |
| Gary H Arlen | Director | Dec. 19, 2008 P | 10,450 | 0 | 0 | $0 |
| Barry Bergsman | Director | Sept. 9, 2008 A | 142,000 | 0 | 0 | $0 |
| Robert B Clasen | Director | Sept. 9, 2008 A | 60,000 | 0 | 0 | $0 |
| Mark D Buckner | Director | June 15, 2007 A | · | 0 | 0 | $0 |
| Esther L Rodriguez | Director | Sept. 30, 2004 A | · | 0 | 0 | $0 |
| Robert M Bennett | Director | Sept. 30, 2004 A | 1,288,017 | 0 | 0 | $0 |
| Charles Cherington | 10% owner | Feb. 10, 2026 P | 6,779,440 | 1 | 0 | $2,000,000 |
| John D Halpern | 10% owner | Dec. 2, 2022 P | 450,961 | 0 | 0 | $0 |
| Robert S. Ellin | 10% owner | Aug. 13, 2020 S | 16,194 | 0 | 0 | $0 |
| Jeffrey Alan Berg | 10% owner | June 3, 2020 S | 276,100 | 0 | 0 | $0 |
| AWM Investment Company, Inc. | 10% owner | March 14, 2018 S | 251,562 | 0 | 0 | $0 |
| Fidelity National Financial, Inc. | 10% owner | Aug. 19, 2009 S | 5,921,811 | 0 | 0 | $0 |
| George P Denny III | · | July 14, 2021 P | 3 | 0 | 0 | $0 |
| Adrian A Pace | · | July 1, 2005 A | · | 0 | 0 | $0 |
| Vincent Carrino | · | May 14, 2004 A | 5,894,831 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 5,684 SH | Aug. 19, 2026 | Daily |
ERNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$30.00
+913.5%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-03Mean target $30.00 +913.5%
Low$30.00
Mean$30.00
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed May 11, 2026